P54991 Pristinamycin IIA synthase subunit A MolNFT, Molecular NFT on GenesisL1

Pristinamycin IIA synthase subunit A

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeidgw6l5iefoirnk5a6wdrxuz43hucgks4xlydiyojy7saojkxgzaq/metadata.json

IPFS of structure file:

bafybeiagm67533qrqsgqg323lyjehdejfsbwprxxlsua7z5lmqcj3lsdlq/AF-P54991-F1-model_v2.pdb

First NFT owner address (eip-55):

0xd91633319BDB0a92cbC4f08DeA734Bf74C030064

First NFT owner address (bech32):

genesis1mytrxvvmmv9f9j7y7zx75u6t7axqxqry8u4g92

Current NFT ID #431567 owner (web3):

0x98e22253e31B07cB0618d7388D8e56673A1A11dF

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
431567
Accession (UniProt):
P54991
Name::
Pristinamycin IIA synthase subunit A
Experimental Method:
Predicted structure
Sequence source:
STREPTOMYCES PRISTINAESPIRALIS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P54991 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P54991|SNAA_STRPR Pristinamycin IIA synthase subunit A OS=Streptomyces pristinaespiralis OX=38300 GN=snaA PE=1 SV=3 MTAPRRRITLAGIIDGPGGHVAAWRHPATKADAQLDFEFHRDNARTLERGLFDAVFIADIVAVWGTRLDSLCRTSRTEHFEPLTLLAAYAAVTEHIGLCATATTTYNEPAHIAARFASLDHLSGGRAGWNVVTSAAPWESANFGFPEHLEHGKRYERAEEFIDVVKKLWDSDGRPVDHRGTHFEAPGPLGIARPPQGRPVIIQAGSSPVGREFAARHAEVIFTRHNRLSDAQDFYGDLKARVARHGRDPEKVLVWPTLAPIVAATDTEAKQRLQELQDLTHDHVALRTLQDHLGDVDLSAYPIDGPVPDIPYTNQSQSTTERLIGLARRENLSIRELALRLMGDIVVGTPEQLADHMESWFTGRGADGFNIDFPYLPGSADDFVDHVVPELQRRGLYRSGYEGTTLRANLGIDAPRKAGAAA

P54991 AF NFT

MOLNFT AF v1

NFT data

MOLNFT P54991 research and analysis (ICN3D with VR)

FASTA sequences

We use cookies on this site to enhance your user experience